Abstract

BackgroundAlthoughmanagement of osteoporosis (OP) is cost-effective in high-risk patients, less than 20% of patients with fragility fracture receive antiresorptive drugs.ObjectivesThe main objective was to evaluate a program for secondary prevention...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call